PRECEDEX DEXMEDETOMIDINE HCI CHLORIDE- dexmedetomidine hydrochloride, sodium chloride injection, solution United States - English - NLM (National Library of Medicine)

precedex dexmedetomidine hci chloride- dexmedetomidine hydrochloride, sodium chloride injection, solution

fareva amboise - dexmedetomidine hydrochloride (unii: 1018wh7f9i) (dexmedetomidine - unii:67vb76hono) - precedex is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting. precedex should be administered by continuous infusion not to exceed 24 hours. precedex has been continuously infused in mechanically ventilated patients prior to extubation, during extubation, and post-extubation. it is not necessary to discontinue precedex prior to extubation. precedex is indicated for sedation of non-intubated patients prior to and/or during surgical and other procedures. none. risk summary available data from published randomized controlled trials and case reports over several decades of use with intravenously administered dexmedetomidine during pregnancy have not identified a drug-associated risk of major birth defects and miscarriage; however, the reported exposures occurred after the first trimester. most of the available data are based on studies with exposures that occurred at the time of caesarean section delivery, and these studies have not i